• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

April 10, 2019

View Archived Issues

BAY-218, a first-in-class AhR antagonist for overcoming tumor-mediated immunosuppression

Read More

How CMV blocks immune recognition

Read More

New bromophenol derivatives as specific PTP1B inhibitors for the treatment of type 2 diabetes

Read More

Mechanism underlying youthful and aging skin found in mice

Read More

Patient enrollment ongoing in phase I study of LYN-00101

Read More

First-in-human data for PLN-74809 support development of the candidate for the treatment of IPF

Read More

First patient enrolled in phase I/II study of NanoDoce for the treatment of bladder cancer

Read More

Enesi Pharma and Oxford Vaccine Group to develop plague vaccine

Read More

Researchers present new oncolytic adenovirus shRNA-based immunotherapy strategy

Read More

A*STAR describes new isoprenylcysteine carboxylmethyltransferase inhibitors

Read More

ImmuneOnco Biopharma reports discovery of novel bispecific antibody-trap, IMM-0306

Read More

Preclinical data presented for a novel cross-linking dependent 4-1BB agonist antibody, PE-0116

Read More

Next-generation of HBV CAMs presented

Read More

Zhejiang Hisun Pharmaceutical discloses mutant c-Kit/PDGFR-alpha inhibitors

Read More

New TLR7 agonists patented by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Read More

University of Nottingham presents CDK12/cyclin K inhibitors

Read More

Protein-arginine deiminase type-4 inhibitors discovered at Jubilant Biosys

Read More

U.S. approval for Evenity for osteoporosis in postmenopausal women at high risk for fracture

Read More

European Commission approves Lynparza for germline BRCA-mutated HER-negative advanced breast cancer

Read More

Discovery and characterization of selective AMPAR/gamma-8 negative modulators as antiepileptics

Read More

Results of phase I trial of RNA-based adjuvant CV-8102 combined with a licensed rabies vaccine

Read More

DNA-encoded monoclonal antibody prevents Zika infection in mice and nonhuman primates

Read More

GHIT Fund grant supports further development of asexual blood-stage malaria vaccine candidate

Read More

Dual kappa/delta-opioid agonist CA-1001 shows efficacy in pain models

Read More

PharmaMar announces new immuno-oncology program

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe